This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Poola, I. Articles by Bonney, G. Search for Related Content PubMed PubMed Citation Articles by Poola, I. Articles by Bonney, G.

Expression of Carcinoembryonic Antigen Cell Adhesion Molecule 6 Oncoprotein in Atypical Ductal Hyperplastic Tissues Is Associated with the Development of Invasive Breast Cancer

Authors' Affiliations: Departments of ¹ Biochemistry and Molecular Biology, ² Pathology, ³ Surgery, and ⁴ Statistical Genetics and Bioinformatics Unit, Howard University College of Medicine, Washington, DC, and ⁵ Biology Department, University of Alberta, Edmonton, Alberta, Canada

Requests for reprints: Indira Poola, Department of Biochemistry and Molecular Biology, Howard University School of Medicine, 520 W Street Northwest, Washington, D.C. 20059. Phone: 202-806-5554; Fax: 202-806-5553/5784; E-mail: ipoola{at}howard.edu.

Background: Epidemiologic studies have established that women with prior atypical ductal hyperplastic (ADH) lesions have a 5-fold increased risk of developing invasive breast cancer (IBC). However, there is currently no means of identifying a subclass of ADH from women who will most likely develop cancer. The purpose of this study is to investigate whether elevated expression of carcinoembryonic antigen cell adhesion molecule 6 (CEACAM6) in ADH tissues is associated with the development of IBC.

Methods: A retrospective study was conducted with archival ADH tissues and clinical information on the development/nondevelopment of IBC. The control group was ADH from patients who had no prior history of IBC and did not develop cancer within 5 years after the diagnosis of ADH (n = 44). The test group was ADH from patients who either developed cancer concurrently or subsequently after diagnosis (ADHC; n = 44). The expression of CEACAM6 was studied by immunohistochemistry and the results were statistically analyzed for significant association to develop cancer (P value), specificity, sensitivity, positive predictive value, and negative predictive value.

Results: Of the 44 control ADH tissues from patients with no history of cancer, 9 were positive for CEACAM6. Among the ADHC tissues, 40 of 44 samples were positive. Statistical analysis of CEACAM6 expression data showed a significant association between its expression and cancer development, high sensitivity, specificity, positive predictive value, and negative predictive value.

Conclusions: The expression of CEACAM6 in ADH lesions is strongly associated with the development of IBC, therefore, it can be applied as a diagnostic marker either singly or in combination with other marker(s) to predict IBC development in women with ADH lesions. It could also be a potential molecular therapeutic target for preventing IBC.

This article has been cited by other articles:

				N. B. Prasad, H. Somervell, R. P. Tufano, A. P.B. Dackiw, M. R. Marohn, J. A. Califano, Y. Wang, W. H. Westra, D. P. Clark, C. B. Umbricht, et al. Identification of Genes Differentially Expressed in Benign versus Malignant Thyroid Tumors Clin. Cancer Res., June 1, 2008; 14(11): 3327 - 3337. [Abstract] [Full Text] [PDF]

				I. Poola, J. Abraham, J. J. Marshalleck, Q. Yue, V. B. Lokeshwar, G. Bonney, and R. L. DeWitty Molecular Risk Assessment for Breast Cancer Development in Patients with Ductal Hyperplasias Clin. Cancer Res., February 15, 2008; 14(4): 1274 - 1280. [Abstract] [Full Text] [PDF]

				L. Maraqa, M. Cummings, M. B. Peter, A. M. Shaaban, K. Horgan, A. M. Hanby, and V. Speirs Carcinoembryonic Antigen Cell Adhesion Molecule 6 Predicts Breast Cancer Recurrence following Adjuvant Tamoxifen Clin. Cancer Res., January 15, 2008; 14(2): 405 - 411. [Abstract] [Full Text] [PDF]

				N. Nishikawa, M. Toyota, H. Suzuki, T. Honma, T. Fujikane, T. Ohmura, T. Nishidate, M. Ohe-Toyota, R. Maruyama, T. Sonoda, et al. Gene Amplification and Overexpression of PRDM14 in Breast Cancers Cancer Res., October 15, 2007; 67(20): 9649 - 9657. [Abstract] [Full Text] [PDF]